Treatment of chronic hepatitis B in Oman experience with lamivudine
<b>Background: </b> Chronic hepatitis B (CHB) in Oman is similar to the Mediterranean Region with significant number of HBeAg negative patients. Interferon therapy is less effective in these patients and lamivudine is an alternative treatment. <b> Patients and Methods: </b> T...
Main Authors: | Upadhyay Dip Amal, Radhakrishnan Sivasankara, Dhar Anjan, Khashoub Masoud, Al Busaidi Sulaiman, Mohan Akkanapragada, Al Zubaidi Ghazi Bin Omer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2003-01-01
|
Series: | The Saudi Journal of Gastroenterology |
Subjects: | |
Online Access: | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2003;volume=9;issue=2;spage=69;epage=74;aulast=Upadhyay |
Similar Items
-
Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
by: Chan Ho Park, et al.
Published: (2016-03-01) -
Rhabdomyolysis due to Lamivudine administration in acute viral hepatitis B infection: a case report from Malaysia
by: Janudin Baharin, et al.
Published: (2014-03-01) -
Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis
by: Cesar Henriquez-Camacho, et al.
Published: (2023-11-01) -
HBV Reactivation and Lamivudine Treatment in Patients with Lymphoma Undergoing Chemotherapy: Four Cases
by: İlhan AFŞAR, et al.
Published: (2006-12-01) -
Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
by: Hu Peng, et al.
Published: (2011-08-01)